We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Coherus BioSciences Inc | NASDAQ:CHRS | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.0437 | 5.59% | 0.825 | 2,136,064 | 00:29:54 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.7904 | 0.825 | 0.8258 | 0.75 | 0.78 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 257.24M | -237.89M | -2.0648 | -0.40 | 90.02M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 00:59:38 | 35 | 0.825 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/1/2024 | 06:59 | DJN | Sandoz to Acquire Cimerli Business from Coherus for $170 Million |
| 26/12/2023 | 21:43 | DJN | Coherus BioSciences Gets FDA OK for Udenyca Injector |
Coherus BioSciences (CHRS) Share Charts1 Year Coherus BioSciences Chart |
|
1 Month Coherus BioSciences Chart |
Intraday Coherus BioSciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
